Replimune Group Inc (REPL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | REPL | RAPP | TYRA | ||
| Company | Replimune Group Inc | Rapport Therapeutics Inc | Tyra Biosciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 11.67 | 21.87 | 16.59 | ||
| High | 11.73 | 22.36 | 16.67 | ||
| Low | 11.25 | 21.00 | 15.84 | ||
| Last | 11.40 | 21.98 | 16.34 | ||
| Change | -0.29 | +0.13 | +0.60 | ||
| % Change | -2.48% | +0.59% | +3.81% | ||
| Volume | 720,000 | 95,800 | 275,900 | ||
| 20-Day Average Volume | 418,400 | 72,605 | 607,940 | ||
| Previous Close | 11.69 | 21.85 | 15.74 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 11.99 | 24.94 | 19.81 | ||
| 20-Day Raw Stochastic | 16.49% | 11.92% | 7.40% | ||
| 20-Day Relative Strength | 48.00% | 46.06% | 37.70% | ||
| Weighted Alpha | +13.07 | N/A | +12.29 | ||
| Today's Opinion | 64% Buy | N/A | 24% Sell | ||
| Previous Opinion | 88% Buy | N/A | 24% Sell | ||
| Last Month's Opinion | 96% Buy | N/A | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.63% since 11/07/24 | -18.29% since 11/07/24 | -4.72% since 11/07/24 | ||
| Low | 11.25 on 11/14/24 | 21.00 on 11/14/24 | 15.60 on 11/11/24 | ||
| High | 12.97 on 11/11/24 | 27.76 on 11/08/24 | 16.96 on 11/08/24 | ||
| 1-Month | |||||
| %Chg | +6.84% since 10/14/24 | -9.88% since 10/14/24 | -25.79% since 10/14/24 | ||
| Low | 9.94 on 10/15/24 | 21.00 on 11/14/24 | 15.28 on 10/30/24 | ||
| High | 12.97 on 11/11/24 | 29.74 on 10/16/24 | 29.60 on 10/24/24 | ||
| 3-Month | |||||
| %Chg | +15.62% since 08/14/24 | +7.75% since 08/14/24 | -24.25% since 08/14/24 | ||
| Low | 9.83 on 08/15/24 | 18.01 on 09/13/24 | 15.28 on 10/30/24 | ||
| High | 12.97 on 11/11/24 | 29.74 on 10/16/24 | 29.60 on 10/24/24 | ||
| 6-Month | |||||
| %Chg | +69.90% since 05/14/24 | N/A since 06/07/24 | -12.06% since 05/14/24 | ||
| Low | 4.92 on 05/29/24 | 16.55 on 08/08/24 | 15.25 on 06/28/24 | ||
| High | 12.97 on 11/11/24 | 29.74 on 10/16/24 | 29.60 on 10/24/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 798,672 | 799,186 | 796,491 | ||
| Shares Outstanding, K | 68,321 | 36,576 | 50,603 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -215,790,000 | -34,790,000 | -69,130,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -53,770,000 | -17,540,000 | -24,020,000 | ||
| 60-Month Beta | 1.19 | N/A | 1.08 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.78 on 08/08/24 | -0.50 on 11/07/24 | -0.41 on 11/07/24 | ||
| Latest Earnings Date | 11/12/24 | 11/14/24 | 11/05/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||